Sponsor:
Universal Diagnostics
Code:
NCT04792684
Conditions
Colorectal Cancer (CRC)
Advanced Adenomas (AA)
Eligibility Criteria
Sex: All
Age: 45 - 70+
Healthy Volunteers: Accepted
Interventions
Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Brief summary:
Conditions
Colorectal Cancer (CRC)
Advanced Adenomas (AA)
Study ID
NCT04792684
Start date
Dec 30, 2020
Status verified date
Nov, 2025
Completion date
Dec 30, 2025
Anticipated
Primary completion date
Dec 30, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 45 - 70+
Healthy Volunteers: Accepted
Enrollment
1300 participants
Anticipated
Arms
Arm A.
Arm B
Interventions
Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Primary outcome measure
Central contacts
Locations
Lakeland Regional Cancer Center
Recruiting
Lakeland, Florida, United States, 33805
Springfield Clinic
Recruiting
Springfield, Illinois, United States, 62702
Mid Hudson Medical Research
Recruiting
New Windsor, New York, United States, 12553
University of Pennsylvania
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Sponsor
Universal Diagnostics
Last update posted
Nov 10, 2025
Last verified
Nov, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Universal Diagnostics on 2025-11-10.